Active, not recruitingNot applicableNCT04419766

Evaluation of IR3535 as a Spatial Repellent for Malaria Control.

Studying Malaria

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Universidade Nova de Lisboa
Principal Investigator
Henrique Silveira, PhD
Universidade Nova de Lisboa, Portugal
Intervention
IR3535 (3-(N-acetyl-N-butyl) aminopropionic acid ethyl ester) house spraying(other)
Enrollment
166 target
Eligibility
All sexes
Timeline
20212025

Study locations (1)

Collaborators

Centro de Investigação Operacional da Beira, Mozambique · Fundação Belmiro de Azevedo, Portugal

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04419766 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria

← Back to all trials